Results 71 to 80 of about 874,057 (168)

Advances in Novel Therapeutic Strategies for Pulmonary Arterial Hypertension

open access: yesCanadian Respiratory Journal, Volume 2026, Issue 1, 2026.
Pulmonary arterial hypertension (PAH) is a progressive, life‐threatening disease characterized by vascular remodeling, endothelial dysfunction, and chronic inflammation. Despite existing targeted therapies, long‐term outcomes remain poor, underscoring the need for more effective treatment.
Yalei Wang   +11 more
wiley   +1 more source

Localized severe scleroderma: a retrospective study of 26 pediatric patients

open access: yes, 2010
Juvenile localized scleroderma includes different conditions characterized by skin hardening with increased collagen deposition. Although juvenile localized scleroderma is considered a relatively benign disease, lesions may extend through the dermis ...
M. Beltramelli   +9 more
core   +1 more source

Juvenile Localized Scleroderma from a Pediatric Rheumatology Perspective: A Single-Center Experience

open access: yes, 2023
Aim: To evaluate juvenile localized scleroderma, which is a disease with high rates of cosmetic and functional sequelae in children, from a pediatric rheumatology perspective.
ÖNER, NİMET   +10 more
core   +1 more source

Identifying Key Questions and Challenges in Microchimerism Biology

open access: yesAdvanced Science, Volume 12, Issue 48, December 29, 2025.
This study identifies key unanswered questions about microchimerism, the presence of cells from one individual living in another. Experts highlight how these cells may affect health, pregnancy, and disease. This study outlines research priorities and challenges in detecting and studying these rare microchimeric cells, aiming to guide future discoveries
Kristine J. Chua   +31 more
wiley   +1 more source

Juvenile Localized Scleroderma: A Very Rare Case

open access: yesDelta Medical College Journal, 2015
Juvenile localized scleroderma (JLS) is a rare chronic inflammatory and fibrosing disorder. It can result in significant morbidity, disfigurement, and severe functional, aesthetic and psychological disabilities. Patients with JLS should be identified early, evaluated extensively, treated aggressively, and monitored carefully.
Md Mahamudul Hasan   +4 more
openaire   +2 more sources

PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Protein arginine methyltransferase 1 (PRMT1) is a pivotal enzyme that catalyzes the asymmetric dimethylation of arginine residues, thereby functioning as a critical epigenetic regulator of diverse biological processes such as gene expression, RNA splicing, and DNA repair.
Yanqun Luo   +4 more
wiley   +1 more source

3233 Von Willebrand Factor is Localized in the Extravascular tissue of Patients with Juvenile Scleroderma

open access: yesJournal of Clinical and Translational Science, 2019
OBJECTIVES/SPECIFIC AIMS: To further explore the role of vWF in the pathogenesis of scleroderma by identifying its location within the tissue of sample biopsies obtained as part of routine diagnosis with the use of immuno-histochemical staining.
Natalia Vasquez Canizares   +4 more
doaj   +1 more source

Disabling pansclerotic morphea of childhood with extracutaneous manifestations

open access: yesIndian Journal of Dermatology, 2013
Disabling pansclerotic morphea (DPM) of childhood is a rare generalized type of localized scleroderma (LS) that is known to follow an aggressive course with pansclerotic lesions leading to severe joint contractures and consequent immobility. Mortality is
Mahendra M Kura, Saurabh R Jindal
doaj   +1 more source

Systemic Sclerosis and Localized Scleroderma in Childhood

open access: yes, 2008
Juvenile scleroderma syndromes, including the systemic and the localized varieties, represent the third most frequent chronic rheumatic conditions in pediatric rheumatology practice.
Zulian F., Francesco Zulian
core   +1 more source

Scleroderma in children

open access: yes, 2017
Juvenile scleroderma with its two varieties, juvenile localized scleroderma and systemic sclerosis (SSc), represents the third most frequent rheumatic disease in childhood.
Francesco Zulian, Zulian F.
core   +1 more source

Home - About - Disclaimer - Privacy